CDLX vs. SIFY, ATGL, RXT, KLTR, BLZE, GDEV, OCFT, LAW, ASUR, and HCAT
Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include Sify Technologies (SIFY), Alpha Technology Group (ATGL), Rackspace Technology (RXT), Kaltura (KLTR), Backblaze (BLZE), GDEV (GDEV), OneConnect Financial Technology (OCFT), CS Disco (LAW), Asure Software (ASUR), and Health Catalyst (HCAT). These companies are all part of the "computer software" industry.
Cardlytics vs. Its Competitors
Cardlytics (NASDAQ:CDLX) and Sify Technologies (NASDAQ:SIFY) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.
Cardlytics has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Sify Technologies has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.
Sify Technologies has a net margin of -2.20% compared to Cardlytics' net margin of -65.41%. Sify Technologies' return on equity of -8.70% beat Cardlytics' return on equity.
In the previous week, Cardlytics had 6 more articles in the media than Sify Technologies. MarketBeat recorded 7 mentions for Cardlytics and 1 mentions for Sify Technologies. Cardlytics' average media sentiment score of 1.07 beat Sify Technologies' score of 0.16 indicating that Cardlytics is being referred to more favorably in the media.
Sify Technologies has higher revenue and earnings than Cardlytics. Cardlytics is trading at a lower price-to-earnings ratio than Sify Technologies, indicating that it is currently the more affordable of the two stocks.
68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 0.6% of Sify Technologies shares are owned by institutional investors. 4.4% of Cardlytics shares are owned by insiders. Comparatively, 77.0% of Sify Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Cardlytics presently has a consensus target price of $3.50, indicating a potential upside of 94.44%. Given Cardlytics' stronger consensus rating and higher probable upside, equities analysts clearly believe Cardlytics is more favorable than Sify Technologies.
Summary
Sify Technologies beats Cardlytics on 9 of the 16 factors compared between the two stocks.
Get Cardlytics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardlytics Competitors List
Related Companies and Tools
This page (NASDAQ:CDLX) was last updated on 7/2/2025 by MarketBeat.com Staff
Free CDLX Stock Alerts